Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000549050 | SCV000629321 | likely benign | Retinoblastoma | 2023-12-03 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV001016457 | SCV001177415 | likely benign | Hereditary cancer-predisposing syndrome | 2017-11-08 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV002281103 | SCV002569638 | uncertain significance | not provided | 2022-02-28 | criteria provided, single submitter | clinical testing | Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this variant does not alter splicing; Has not been previously published as pathogenic or benign to our knowledge |
All of Us Research Program, |
RCV000549050 | SCV004847083 | likely benign | Retinoblastoma | 2023-12-13 | criteria provided, single submitter | clinical testing |